Tenet Healthcare CORP Form 4 insider transactions

Tenet Healthcare's CEO, Saumya Sutaria, reports the acquisition of 54,728 restricted stock units in a recent SEC filing.

Paola M. Arbour, EVP and Chief Information Officer of Tenet Healthcare Corp, reports the acquisition of 3,801 restricted stock units.

EVP, Chief Admin. Officer & GC of Tenet Healthcare, Thomas W. Arnst, reports the acquisition of 11,402 restricted stock units.

Lisa Y. Foo, EVP of Commercial Operations at Tenet Healthcare, reports the vesting and subsequent transactions of restricted stock units and performance share units.

Paola M. Arbour, EVP and Chief Information Officer of Tenet Healthcare, reported the vesting of restricted stock units and subsequent transactions to cover tax obligations.

Tenet Healthcare CEO Saumya Sutaria reports the vesting and conversion of restricted stock units into common stock, along with transactions to cover tax obligations.

R. Scott Ramsey, Principal Accounting Officer of Tenet Healthcare Corp, reports the vesting and subsequent transactions of restricted stock units and performance share units.

EVP, Chief Admin. Officer & GC of Tenet Healthcare, Thomas W. Arnst, reports the vesting and subsequent transactions of restricted stock units and performance share units.

Principal Accounting Officer R. Scott Ramsey of Tenet Healthcare Corp. reports the acquisition of 6,311 shares of common stock due to the vesting of performance-based restricted stock.

EVP, Chief Admin. Officer & GC of Tenet Healthcare, Thomas W. Arnst, reports acquisition of 25,244 shares of common stock on February 11, 2025, due to performance-based restricted stock vesting.

Saumya Sutaria, CEO of Tenet Healthcare, reports the acquisition of 126,203 shares of common stock following the achievement of performance-based restricted stock targets.

Paola M. Arbour, EVP and Chief Information Officer of Tenet Healthcare, reports the acquisition of 12,622 shares of common stock and disposal of 34,048 shares following the vesting of performance-based restricted stock.

Lisa Y. Foo, EVP of Commercial Operations at Tenet Healthcare Corp, reports the acquisition of 12,622 shares of common stock and disposal of 28,188 shares on February 11, 2025.

Tenet Healthcare's CEO, Saumya Sutaria, was granted 52,065 restricted stock units that vest annually over four years.

Lisa Foo, EVP of Commercial Operations at Tenet Healthcare, reported the sale of 4,000 shares of common stock on October 31, 2024.

R. Scott Ramsey, Principal Accounting Officer of Tenet Healthcare Corp, sold 11,599 shares of common stock at an average price of $162.06 on September 5, 2024.

Director Richard W. Fisher sold shares of Tenet Healthcare Corp (THC) on August 27, 2024.

Paola M. Arbour, EVP and Chief Information Officer of Tenet Healthcare Corp, reported the sale of 8,377 shares of common stock on August 16, 2024.

Tenet Healthcare's Chairman and CEO, Saumya Sutaria, recently sold shares of the company's common stock.

Director Meghan FitzGerald sold 20,000 shares of Tenet Healthcare Corp (THC) at an average price of $146.34 on August 6, 2024.

Director Richard W. Fisher sold 1,400 shares of Tenet Healthcare Corp (THC) at a price of $132.24 on June 10, 2024.

Tenet Healthcare's CEO, Saumya Sutaria, recently transferred 100,000 shares of common stock to his wife as a gift.

Director Christopher S. Lynch sold 10,861 shares of Tenet Healthcare Corp (THC) on May 30, 2024, at an average price of $133.83.

Director J. Robert Kerrey reported multiple sales and gift transactions involving Tenet Healthcare Corp (THC) common stock between May 30 and May 31, 2024.

Director Richard J. Mark reported the acquisition of restricted stock units in Tenet Healthcare Corp on May 23, 2024.

Director J. Robert Kerrey reported the acquisition of 1,939 restricted stock units of Tenet Healthcare Corp on May 23, 2024.

Director Vineeta Agarwala reported the acquisition of 1,551 restricted stock units in Tenet Healthcare Corp on May 23, 2024, which vest on the first anniversary of the grant date.

Meghan FitzGerald, a director of Tenet Healthcare Corp, reported the acquisition of 1,551 restricted stock units on May 23, 2024, according to a Form 4 filing with the SEC.

Director Tammy Romo received 1,551 restricted stock units of Tenet Healthcare Corp on May 23, 2024, which vest on the first anniversary of the grant date.

Director Stephen H. Rusckowski reports acquisition of 1,551 restricted stock units in Tenet Healthcare Corp.